One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Is It PRIME Time for Biparametric Magnetic Resonance Imaging in Prostate Cancer Diagnosis?
AlexanderNgabPramitKhetrapalcdVeeruKasivisvanathanbc
Transperineal Prostate Biopsy Is the New Black: What Are the Next Targets?
LouisLenfantaEricBarretbMorganRouprêtaFrancoisRozetbGuillaumePloussardcPierreMozeraCancerology Committee of Association Française d'Urologie (CCAFU)
What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021
FabioTurcoabAndrewArmstrongcGerhardtAttarddTomasz M.BeereHimishaBeltranfAndersBjartellgAlbertoBossihAlbertoBrigantiiRob G.BristowjkMuhammadBulbullOrazioCaffomKim N.ChinCarolineClarkeoNoelClarkepIan D.DavisqJohannde BonorIgnacioDuransRosEelest…AureliusOmlincyda1
Cost-Effectiveness of the Stockholm3 Test and Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study
ShuangHaoaEmelieHeintzbEllinorÖstenssonaAndreaDiscacciatiaFredrikJäderlingcdHenrikGrönbergaMartinEklundaTobiasNordströmae1Mark S.Clementsa1
Improved Harm/Benefit Ratio and Cost-effectiveness of Prostate Cancer Screening Using New Technologies
Eveline A.M.HeijnsdijkHarry J.de Koning
Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study
Evan Y.YuaMichael P.KolinskybWilliam R.BerrycMargittaRetzdLoicMoureyeJosep M.PiulatsfLeonard J.ApplemangEmanuelaRomanohGwenaelleGravisiHowardGurneyjMartinBögemannkUrbanEmmeneggerlAnthony M.JoshuamMarkLinchnSrikalaSridharoHenry J.ConterpBrigitteLaguerreqChristopheMassardrs…Johann S.de Bonou
Key Notes on Pembrolizumab and Docetaxel Combination Therapy for Metastatic Castration-Resistant Prostate Cancer
Maxton E.ThomanaKeyanSalariab
International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin–exposed High-risk Non–muscle-invasive Bladder Cancer
MathieuRoumiguiéabAshish M.KamatcTrinity J.BivalacquadSeth P.LernereWassimKassouffAndreasBöhleghMaurizioBrausiiRogerBuckleyjRajPersadkMarcColombellDonaldLammmJuanPalou-RedortanMarkSolowayoKenBrotherspGarySteinbergqYairLotanrRichardSylvestersJ.Alfred WitjestPeter C.Blacka
Optimizing Clinical Trial Design for Patients with Non–muscle-invasive Bladder Cancer
ChanaWeinstockSundeepAgrawalElaineChang
European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence
Arjun K.NambiaraSalvadorArlandisbKariBøcHannyCobussen-BoekhorstdElisabettaCostantinieMonicade HeidefFawzyFaragghJanGroeniMarkosKaravitakisjMarie CarmelaLapitankMargaridaMansolSerenella MonagasArteagamAisling Nic AnRioghnEabhannO'ConnoroMuhammad ImranOmarpqBenoitPeyronnetrVeroniquePhésVasileios I.Sakalist…Christopher K.Hardingay
European Association of Urology Guidelines on the Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 2: Underactive Bladder, Bladder Outlet Obstruction, and Nocturia
SalvadorArlandisaKariBøbHannyCobussen-BoekhorstcElisabettaCostantinidMonicade HeideeFawzyFaragfgJanGroenhMarkosKaravitakisiMarie CarmelaLapitanjMargaridaMansokSerenella MonagasArteagalArjun K.NambiarmAisling Nic AnRioghnEabhannO'ConnoroMuhammad ImranOmarpBenoitPeyronnetqrVeroniquePhésVasileios I.Sakalist…Christopher K.Hardingmy
Newly Released Guidelines on Female Non-neurogenic Lower Urinary Tract Symptoms: Resuscitating Female Urology
Jean-NicolasCornu
Thulium Fibre Laser versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial
ØyvindUlvikabMathias SørstrandÆsøyaPatrickJuliebø-JonesabPederGjengstøaChristianBeislandab
Thulium Fiber Laser: A Leap Towards Stone-free Status?
DimaRaskolnikovJonathan D.Harper
Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysis
PawelRajwaabBenjaminPradereaGiorgioGandagliacRoderick C.N.van den BerghdIgorTsaureSung RyulShimfTakafumiYanagisawaagEkaterinaLaukhtinaahKeiichiroMoriagHadiMostafaeiaiFahadQuhalajPiotrBryniarskibEvaCompératkGuilhemRoubaudlChristopheMassardmAxel S.MerseburgernMichael S.LeapmanoDaniel E.Sprattp…GuillaumePloussardy
Robot-assisted Prostate-specific Membrane Antigen–radioguided Salvage Surgery in Recurrent Prostate Cancer Using a DROP-IN Gamma Probe: The First Prospective Feasibility Study
Hilda A.de BarrosabMatthias N.van OosteromacMaarten L.DonswijkdJeroen J.M.A.HendrikxdeAndré N.VisbfTobiasMaurerghFijs W.B.van LeeuwenacHenk G.van der PoelabfPim J.van Leeuwenab
High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient–data Network Meta-analysis from the MARCAP Consortium
Amar U.KishanabXiaoyanWangcYilunSundeTahminehRomerocJeff M.MichalskifTing MartinMaaFelix Y.FenggHoward M.SandlerhMichelBollaiPhilippeMaingonjTheoDe ReijkekAnoukNevenlmAllisonSteiglernJames W.DenhamnDavidJosephoAbdenourNabidpNathalieCarrierqLuisSouhamir…Daniel E.Spratte
Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021
SilkeGillessenabcdAndrewArmstrongeGertAttardfTomasz M.BeergHimishaBeltranhAndersBjartelliAlbertoBossijAlbertoBrigantikRobert G.BristowdlMuhammadBulbulmOrazioCaffonKim N.ChioCaroline S.ClarkepNoelClarkeqIan D.DavisrJohann S.de BonosIgnacioDurantRosEeless…AureliusOmlinci
Re: Oncological Benefit of Re-resection for T1 Bladder Cancer: A Comparative Effectiveness Study
J.Alfred Witjes
Re: Fertility Potential Is Compromised in 20% to 25% of Boys with Nonsyndromic Cryptorchidism Despite Orchidopexy Within the First Year of Life
ChristianRadmayr
Re: Targeted Prostate Biopsy: Umbra, Penumbra, and Value of Perilesional Sampling
Anwar R.PadhaniaIvo G.SchootsbcGianlucaGiannarinid
Re: Survival After Radical Prostatectomy Versus Radiation Therapy in High-risk and Very High-risk Prostate Cancer
DmitryPushkarAlexanderGovorov
Re: Performance of a Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography–derived Risk-stratification Tool for High-risk and Very High-risk Prostate Cancer
AndersBjartell
Re: Darolutamide and Survival in Metastatic, Hormone-sensitive Prostate Cancer
KennethChenaAoifeMcVeyaVeeruKasivisvanathanabPocharapongJenjitranantaArunAzadcdDeclan G.Murphyad
Re: Zachary Klaassen, Emily Vertosick, Andrew J. Vickers, et al. Optimal Dissemination of Scientific Manuscripts via Social Media: A Prospective Trial Comparing Visual Abstracts Versus Key Figures in Consecutive Original Manuscripts. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.01.041
BenjaminDaviesaKeithKowalczykb
Reply to Benjamin Davies, Keith Kowalczyk RE: Zachary Klaassen, Emily Vertosick, Andrew J. Vickers, et al. Optimal Dissemination of Scientific Manuscripts via Social Media: A Prospective Trial Comparing Visual Abstracts Versus Key Figures in Consecutive Original Manuscripts. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.01.041
ZacharyKlaassenaJames W.F.CattobAndrew J.VickerscMatthew R.CooperbergdAlexanderKutikove
Reply to Yu Wei, Yao Zhu, and Dingwei Ye's Letter to the Editor re: Fabio Turco, Andrew Armstrong, Gerhardt Attard, et al. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. Eur Urol. 2022;82:6–11
F.TurcoabM.SmithcA.OmlindhS.Gillessenefghi
Re: Fabio Turco, Andrew Armstrong, Gerhardt Attard, et al. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. Eur Urol. 2022;82:6–11
YuWeiabYaoZhuabDingweiYeab
Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019
HemamaliSamaratungaabBrettDelahuntcLarsEgevadd
Re: Matthew R. Smith, Maha Hussain, Fred Saad, et al. Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. N Engl J Med. 2022;386:1132–1142
GiuseppeDi LorenzoabCarloBuonerbaa
Corrigendum to “What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021� [Eur Urol 82(1):6–11]
FabioTurcoabAndrewArmstrongcGerhardtAttarddTomasz M.BeereHimishaBeltranfAndersBjartellgAlbertoBossihAlbertoBrigantiiRob G.BristowjkMuhammadBulbullOrazioCaffomKim N.ChinCarolineClarkeoNoelClarkepIan D.DavisqJohannde BonorIgnacioDuransRosEelest…AureliusOmlincydaâ€
Corrigendum to “Intracorporeal Versus Extracorporeal Robot-assisted Kidney Autotransplantation: Experience of the ERUS RAKT Working Group� [Eur Urol 2022;81(2):168–75]
AlbertoBredaa†PietroDianaab†AngeloTerritoaAndreaGallioliaAlbertoPianaaJosep MariaGayaaPavelGavrilovaLiesbethDesendercBenjaminVan ParysdCharlesVan PraetdEdwardLambertdZine-EddineKheneeVan ThiDangfNicolasDoumercf‡KarelDecaesteckerd‡
Corrigendum to “Cost-Effectiveness of the Stockholm3 Test and Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study� [Eur Urol 2022]
ShuangHaoaEmelieHeintzbEllinorÖstenssonaAndreaDiscacciatiaFredrikJäderlingcdHenrikGrönbergaMartinEklundaTobiasNordströmae1Mark S.Clementsa1
